Brzozowa-Zasada, M.; Piecuch, A.; Bajdak-Rusinek, K.; Janelt, K.; Michalski, M.; Klymenko, O.; Matysiak, N.
Immunohistochemical Expression of Glutathione Peroxidase 1 (Gpx-1) as an Independent Prognostic Factor in Colon Adenocarcinoma Patients. Pharmaceuticals 2023, 16, 740.
https://doi.org/10.3390/ph16050740
AMA Style
Brzozowa-Zasada M, Piecuch A, Bajdak-Rusinek K, Janelt K, Michalski M, Klymenko O, Matysiak N.
Immunohistochemical Expression of Glutathione Peroxidase 1 (Gpx-1) as an Independent Prognostic Factor in Colon Adenocarcinoma Patients. Pharmaceuticals. 2023; 16(5):740.
https://doi.org/10.3390/ph16050740
Chicago/Turabian Style
Brzozowa-Zasada, Marlena, Adam Piecuch, Karolina Bajdak-Rusinek, Kamil Janelt, Marek Michalski, Olesya Klymenko, and Natalia Matysiak.
2023. "Immunohistochemical Expression of Glutathione Peroxidase 1 (Gpx-1) as an Independent Prognostic Factor in Colon Adenocarcinoma Patients" Pharmaceuticals 16, no. 5: 740.
https://doi.org/10.3390/ph16050740
APA Style
Brzozowa-Zasada, M., Piecuch, A., Bajdak-Rusinek, K., Janelt, K., Michalski, M., Klymenko, O., & Matysiak, N.
(2023). Immunohistochemical Expression of Glutathione Peroxidase 1 (Gpx-1) as an Independent Prognostic Factor in Colon Adenocarcinoma Patients. Pharmaceuticals, 16(5), 740.
https://doi.org/10.3390/ph16050740